Erspamer et al, “Deltorphins: A Family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites,” Proceedings of the National Academy of Sciences of the USA, 86, 13 (Jul. 1989). |
Comer, “BW373U86: Behavorial Pharmacology of a Putative Non-Peptide, Systemically-Active Delta Opioid Agonist,” Dissertation Abstracts Inernational, 53(5B). 2578 (Jul. 1, 1992-entered in the University of Michigan on-line catalog). |
Pakarinen, E.D., “Effects of Convulsant Agents on Learning and Memory in Squirrel Monkeys,” Dissertation Abstracts International, 54(O1B), 189(Mar. 31, 1993-entered in the Louisiana State University on-line catalog). |
Selley, “BW373U86 A Non-peptide ∂-Opioid Agonist With Novel Receptor —G-Protein-Mediated Actions,” Meeting of the International Narcotics Research Conference (INRC). Skoevde, Sweden, Abstract (Jul. 11-16, 1993). |
Calderon, S.N. et al., “Synthesis and Absolute Configuration of Optically Pure Enantimeters of (=)-BW373U86, A Nonpeptide ∂-Opioid Receptor Agonist,” College on Problems of Drug Dependence, Inc., Fifty-fifth Annual Scientific Meeting, Toronto, Canada, Poster Presentation. (Jun. 12-17, 1993). |
Dykstra et al., “Effects of a Novel Delta Opioid Agonist in Squirrel Monkeys Responding Under a Schedule of Shock Titration,” Meeting of the Internaional Narcotics Research Conference (INRC). Keystone, Colorado, Abstract, (Jun. 23-27, 1992). |
Porreca et al., “Pharmacology of Multiple Opioid Delta Receptors,” National Institute on Drug Abuse Research Monograph Series 132, Problems of Drug Dependence, 1992: Proceeding of the 54th Annual Scientific Meeting, 430-436 (1993). |
Iwamoto et al., “Calcium Antagonism, by KB-2796, a New Diphenylpiperazine analogue in Dog Vascular Smooth Muscle,” J. Pharm. Pharmocol., 43, 535-539 (1991). |
Goenechea et al., “Untersuchengen zur Biotransformation von Meclozin im Menschlichen Korper,” J. Clin. Chem. Clin. Biochem., 26, 105-115 (1988)—See specification, p. 4, last paragraph and Chemical Abstracts 108: 215746g. |
Iwamoto et al, “Effects of KB-2796, a New Calcium Antagonist, and Other Diphenylpiperazines on [3H]Nitrendipine Binding,”Japan J. Pharmacol., 48, 241-247 (1988). |
Meuldermas et al, “Plasma Levels, Biotransformation and Excretion of Oxatomide (R 35 443) in Rats, Dogs and Man,” Xenobiotica, 14(6), 445-462 (1984). |
Krishnamurthy, “A Highly Efficient and General N-Monomethylation of Functionalized Primary Amines via Formylation-Borane: Methyl Sulfide Reduction,” Tet. Let., 23(33), 3315-3318 (1982). |
Lord, et al., “Endogenous Opioid Peptides: Multiple Agonists and Receptors,” Nature, 267, 495-499 (1977). |
Chang, et al., “A Novel, Potent and Selective Nonpeptide Delta Opioid Receptor Agonist BW373U86,” J. Pharmacol. Exp. Ther., 267, 582-857 (1993). |
Childers, et al., “BW373U86: A Non-peptide ∂Opioid Agonist With Novel Receptors-g Protein-mediated Actions in Rat Brain Membranes and Neuroblastonma Cells,” Molec. Pharacol., 44, 827-834 (1993). |
Comer, et al., “Convulsive Effects of Systemic Adminstration on the Delta Opioid Agonist BW373U86 in Mice,” J. Pharmacol. Exp. Ther., 267, 888-895 (1993). |
Comer, et al., “Discriminative stimulus Effects of BW373U86: A Non-peptide Ligand With Selectivly for Delta Opioid Receptors,” J. Pharmacol. Exp. Ther., 267, 866-874 (1993). |
Dykstra, et al., “A Novel Delta Opioid Agonist, BW373U86, in Squirrel Monkeys Responding Under a Schedule of Shock Titration,” J. Pharmacol. Exp. Ther., 267, 875-882 (1993). |
Lee, et al., “A Nonpeptidic Delta-opioid Receptor Agonist, BW373U86, Attenuates the Development and Expression of Morphine Abstinence Precipitated by Naloxome in Rat . . . ,” J. Pharmacol. Exp. Ther., 267, 896-903 (1993). |
Negus et al., “Effects of Opioid Receptor Agonists Selective for Mu, Kapa and Delta Opioid Receptors on Schedule-controlled Responding in Rhesus Monkeys: Antagonism by Quadazocine,” J. Pharmacol. Exp. Ther., 267, 896-903 (1993). |
Wild, et al., “Binding of 373U86, A Non-peptide ∂-Opioid Receptor Agonist, is not Regulated ny Guanine Nucleotides and Sodium,” Eur. J. Pharmacol,-Molec. Pharmacol, Section 246, 289-292 (1993). |
Wild, et al., “Antinociceptive Actions of BW373U86 in the Mouse,” J. Pharmacol., Exp. Ther. 267, 858-865, 1993. |
Xu, et al., “Differential Binding of Opioid Peptides and Other Drugs to Two Subtypes of Opioid ∂nex Binding Sites in Mouse Brain: Further Evidence of ∂ Receptor Heterogeneity,” Peptides 14, 893-907 (1993). |
Campa, et al., “Characterization of ∂Opioid Receptors in Lung Cancer Using a Novel Nonpeptide Ligand,” Cancer Research 56, 1965-1701, 1996. |
Schellenberg, Karl A., “The Synthesis of Secondary and Tertiary Amines by Borohydride Reduction,” J. Org. Chem., Nov. 1963, pp. 3259-3261. |
Dieter Sebach, et al., Diastereoselektive Synthese Neuartiger Mannich-Basen (mitels Titanderivaten), Hevetica Chemica Acta., vol. 67 (1984), pp. 1593-1597. |
Barton, Derek H.R., et al., “Copper Salts Catalysis of N-Phenylation of Amines by Trivalent Organobismuth Compounds,” Tetrahedron Letters, vol. 28, No. 8 pp. 887-890, 1987. |
Jung, Michael E., et al., “Organic Chemistry of L-tyrosine, 1. General Synthesis of Chiral Piperazines from Amion Acids,” J. Org. Chem., 1985, 50, 4909-4913. |
Harland, Philip A., et al., Synthesis of Primary Amines via Alkylation of the Sodium Salt of Trifluroacetamide: An Alternative to the Gabriel Synthesis,: Synthesis, Nov. 1984, pp. 941-944. |
Tyle, Praveen, Review: “Iontophoretic Devices for Drug Delivery,” Pharmaceutical Research, vol. 3, No. 6, 1986, pp. 318-326. |
Broadbent et al., “Role of Opioid Receptor Subtypes in the Discriminative Stimulus Effects of Cocaine,” Meeting of the International Narcotics Research Conference (INRC). Keystone, Colorado, Abstract, (Jun. 23-27, 1992). |
Dworkin et al., “Effects of ∂-Opiate Agonists on cocaine and Heroin Self Administration in Rats,” Meeting of the International Narcotics Research Conference (INRC). Keystone, Colorado, Abstract, (Jun. 23-27, 1992). |
Lee et al., “Non-peptide Delta-Opioid Receptor Agonist BW373U86 Suppresses Naloxone-precidpated Morphine Abstinence,” Meeting of the International Narcotics Research Conference (INRC). Keystone, Colorado, Abstract, (Jun. 23-27, 1992). |
Natsuka et al., “Synthesis and Structure-Activity Relationship of 1-Substitued 4-(1,2-Diphenylethyl)piperazine Derivatives having Narcotic Agonist and Antagonist Activity,” J. Med. Chem., 30(10), 1779-1787 (1987). |